|
Simultaneous Sessions
Monday, December 11, 2006: 7:30 a.m. - 9:00 a.m.
- Red Cell Structure/Function, Metabolism, and Survival, including Iron, I Room 240
- Congenital Bone Marrow Failure Syndromes, Room 314
- Integrins and Other Membrane Glycoproteins, Room 414 AB
- Factor V and Factor VIII, Room 109
- Coagulation and von Willebrand Factor, Room 414 CD
- Risk Factors for Thrombosis, Room 110
- Stem Cell Plasticity, Room 224 ABEF
- Malignant Stem and Progenitor Cells, Room 311 E-H
- Novel Therapeutic Pathways, Room 315
- Leukemias: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis - Pediatric Leukemias, Room 311 A-D
- Acute Myeloid Leukemia: Molecular Targets and Molecular Profiling, Halls F1-F2
- Acute Lymphocytic Leukemias: Chemotherapy Advances, Room 330
- Acute Myeloid Leukemia: Novel Therapies, Hall F5
- Lymphoma Biology with a Focus on the Germinal Center, Halls F3-F4
- Immunochemotherapy of Diffuse Large B-Cell Lymphoma, Valencia Room D
- Lymphoma: Pre-Clinical - Chemotherapy and Biologic Agents I, Room 224 CDGH
- Chronic Myeloid Leukemia: Treatment Beyond Imatinib and Novel BCR-ABL Inhibitors, Valencia Room A
- Myelodysplastic Syndromes: Cytogenetics, Prognosis, and Treatment, Valencia Room BC
- Multiple Myeloma: Pathophysiology and In Vivo Modeling, Chapin Theater (Level III)
- Experimental Transplantation: Emerging Concepts in Graft-Versus-Leukemia (GVL), Room 230
- Recurrence after Allogeneic Transplantation, Room 304 E-H
- Clinical Results: Unrelated Donor Transplantation, Room 304 A-D
- Gene Therapy I: Clinical and Large Animal Studies, Room 312
|
